Verastem Toekomstige groei
Future criteriumcontroles 2/6
Verastem is forecast to grow earnings and revenue by 25.8% and 57.1% per annum respectively while EPS is expected to grow by 41.3% per annum.
Belangrijke informatie
25.8%
Groei van de winst
41.3%
Groei van de winst per aandeel
| Biotechs winstgroei | 27.1% |
| Inkomstengroei | 57.1% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 01 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Verastem: Narrowed Market And Less Compelling Efficacy Warrant Rating Downgrade
May 26Verastem: Moving Forward
Sep 13Health Check: How Prudently Does Verastem (NASDAQ:VSTM) Use Debt?
Sep 01
Verastem Non-GAAP EPS of -$0.11 in-line
Aug 08Verastem: Looking Increasingly Attractive
Jun 29Verastem: Time To Take My Position Out Of Mothball
Apr 19Vectoring In On Verastem
Jan 12Verastem: Buying Opportunity Following Unjustified Sell-Off
Sep 22Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 57 | -99 | -94 | -95 | 8 |
| 12/31/2025 | 18 | -120 | -113 | -109 | 9 |
| 12/31/2024 | 7 | -106 | -108 | -130 | 9 |
| 6/30/2024 | 10 | -89 | -102 | -102 | N/A |
| 3/31/2024 | N/A | -106 | -95 | -94 | N/A |
| 12/31/2023 | N/A | -87 | -86 | -86 | N/A |
| 9/30/2023 | N/A | -77 | -73 | -73 | N/A |
| 6/30/2023 | N/A | -75 | -72 | -72 | N/A |
| 3/31/2023 | N/A | -73 | -65 | -65 | N/A |
| 12/31/2022 | 3 | -74 | -64 | -64 | N/A |
| 9/30/2022 | 3 | -73 | -57 | -57 | N/A |
| 6/30/2022 | 3 | -78 | -53 | -53 | N/A |
| 3/31/2022 | 4 | -73 | -53 | -53 | N/A |
| 12/31/2021 | 2 | -71 | -54 | -54 | N/A |
| 9/30/2021 | 2 | -75 | -65 | -65 | N/A |
| 6/30/2021 | 81 | -39 | -10 | -10 | N/A |
| 3/31/2021 | 84 | -45 | -19 | -19 | N/A |
| 12/31/2020 | 89 | -68 | -34 | -34 | N/A |
| 9/30/2020 | 92 | -87 | -49 | -49 | N/A |
| 6/30/2020 | 22 | -130 | -122 | -122 | N/A |
| 3/31/2020 | 21 | -149 | -134 | -134 | N/A |
| 12/31/2019 | 17 | -149 | -139 | -139 | N/A |
| 9/30/2019 | 15 | -122 | -143 | -120 | N/A |
| 6/30/2019 | 22 | -113 | -138 | -115 | N/A |
| 3/31/2019 | 28 | -89 | -114 | -91 | N/A |
| 12/31/2018 | 27 | -72 | -98 | -75 | N/A |
| 9/30/2018 | 26 | -79 | -77 | -76 | N/A |
| 6/30/2018 | 10 | -81 | -66 | -65 | N/A |
| 3/31/2018 | N/A | -76 | N/A | -69 | N/A |
| 12/31/2017 | N/A | -68 | N/A | -57 | N/A |
| 9/30/2017 | N/A | -61 | N/A | -43 | N/A |
| 6/30/2017 | N/A | -46 | N/A | -37 | N/A |
| 3/31/2017 | N/A | -41 | N/A | -29 | N/A |
| 12/31/2016 | N/A | -36 | N/A | -29 | N/A |
| 9/30/2016 | N/A | -37 | N/A | -34 | N/A |
| 6/30/2016 | N/A | -44 | N/A | -39 | N/A |
| 3/31/2016 | N/A | -51 | N/A | -45 | N/A |
| 12/31/2015 | N/A | -58 | N/A | -46 | N/A |
| 9/30/2015 | N/A | -60 | N/A | -45 | N/A |
| 6/30/2015 | N/A | -58 | N/A | -43 | N/A |
| 3/31/2015 | N/A | -55 | N/A | -39 | N/A |
| 12/31/2014 | N/A | -53 | N/A | -37 | N/A |
| 9/30/2014 | N/A | -51 | N/A | -34 | N/A |
| 6/30/2014 | N/A | -48 | N/A | -32 | N/A |
| 3/31/2014 | N/A | -45 | N/A | -29 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: VSTM is forecast to remain unprofitable over the next 3 years.
Winst versus markt: VSTM is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: VSTM is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: VSTM's revenue (57.1% per year) is forecast to grow faster than the US market (8.9% per year).
Hoge groei-inkomsten: VSTM's revenue (57.1% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if VSTM's Return on Equity is forecast to be high in 3 years time